ID   LYRIC_RAT               Reviewed;         581 AA.
AC   Q9Z1W6;
DT   21-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2001, sequence version 2.
DT   24-JUL-2024, entry version 142.
DE   RecName: Full=Protein LYRIC;
DE   AltName: Full=Lysine-rich CEACAM1 co-isolated protein;
DE   AltName: Full=Metadherin;
DE   AltName: Full=Metastasis adhesion protein;
GN   Name=Mtdh; Synonyms=Lyric;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING, TISSUE
RP   SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   STRAIN=Fischer; TISSUE=Bile duct;
RX   PubMed=15383321; DOI=10.1016/j.yexcr.2004.06.026;
RA   Britt D.E., Yang D.-F., Yang D.-Q., Flanagan D.L., Callanan H., Lim Y.-P.,
RA   Lin S.-H., Hixson D.C.;
RT   "Identification of a novel protein, LYRIC, localized to tight junctions of
RT   polarized epithelial cells.";
RL   Exp. Cell Res. 300:134-148(2004).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-297; SER-425; SER-456 AND
RP   SER-567, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Down-regulates SLC1A2/EAAT2 promoter activity when expressed
CC       ectopically. Activates the nuclear factor kappa-B (NF-kappa-B)
CC       transcription factor. Promotes anchorage-independent growth of
CC       immortalized melanocytes and astrocytes which is a key component in
CC       tumor cell expansion. Promotes lung metastasis and also has an effect
CC       on bone and brain metastasis, possibly by enhancing the seeding of
CC       tumor cells to the target organ endothelium. Induces chemoresistance
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with BCCIP, CREBBP/CBP and RELA/p65. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250};
CC       Single-pass membrane protein {ECO:0000250}. Nucleus membrane
CC       {ECO:0000250}; Single-pass membrane protein {ECO:0000250}. Cell
CC       junction, tight junction {ECO:0000250}. Nucleus, nucleolus
CC       {ECO:0000250}. Cytoplasm, perinuclear region {ECO:0000250}. Note=In
CC       epithelial cells, recruited to tight junctions (TJ) during the
CC       maturation of the TJ complexes. A nucleolar staining may be due to
CC       nuclear targeting of an isoform lacking the transmembrane domain. TNF-
CC       alpha causes translocation from the cytoplasm to the nucleus (By
CC       similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9Z1W6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Z1W6-2; Sequence=VSP_012227;
CC       Name=3;
CC         IsoId=Q9Z1W6-3; Sequence=VSP_012228;
CC       Name=4;
CC         IsoId=Q9Z1W6-4; Sequence=VSP_012227, VSP_012228;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest levels in liver,
CC       kidney, prostate and small intestine. Not detected in endothelial
CC       cells. {ECO:0000269|PubMed:15383321}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF100421; AAC72405.2; -; mRNA.
DR   RefSeq; NP_596889.1; NM_133398.1. [Q9Z1W6-1]
DR   AlphaFoldDB; Q9Z1W6; -.
DR   IntAct; Q9Z1W6; 5.
DR   STRING; 10116.ENSRNOP00000009989; -.
DR   iPTMnet; Q9Z1W6; -.
DR   PhosphoSitePlus; Q9Z1W6; -.
DR   SwissPalm; Q9Z1W6; -.
DR   jPOST; Q9Z1W6; -.
DR   PaxDb; 10116-ENSRNOP00000009989; -.
DR   PeptideAtlas; Q9Z1W6; -.
DR   GeneID; 170910; -.
DR   KEGG; rno:170910; -.
DR   UCSC; RGD:620992; rat. [Q9Z1W6-1]
DR   AGR; RGD:620992; -.
DR   CTD; 92140; -.
DR   RGD; 620992; Mtdh.
DR   VEuPathDB; HostDB:ENSRNOG00000006870; -.
DR   eggNOG; ENOG502QU7P; Eukaryota.
DR   HOGENOM; CLU_034908_0_0_1; -.
DR   InParanoid; Q9Z1W6; -.
DR   OrthoDB; 5363141at2759; -.
DR   PhylomeDB; Q9Z1W6; -.
DR   TreeFam; TF331350; -.
DR   PRO; PR:Q9Z1W6; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000006870; Expressed in quadriceps femoris and 19 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0005923; C:bicellular tight junction; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISO:RGD.
DR   GO; GO:0046581; C:intercellular canaliculus; IDA:RGD.
DR   GO; GO:0016604; C:nuclear body; ISO:RGD.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0003725; F:double-stranded RNA binding; ISO:RGD.
DR   GO; GO:0051059; F:NF-kappaB binding; ISS:UniProtKB.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0003713; F:transcription coactivator activity; ISO:RGD.
DR   GO; GO:0003712; F:transcription coregulator activity; IBA:GO_Central.
DR   GO; GO:0070830; P:bicellular tight junction assembly; IEP:RGD.
DR   GO; GO:0031663; P:lipopolysaccharide-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0010508; P:positive regulation of autophagy; ISO:RGD.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   InterPro; IPR031402; LYRIC.
DR   InterPro; IPR052305; TransReg_TumorExp.
DR   PANTHER; PTHR23251; LYSINE-RICH CEACAM1 CO-ISOLATED PROTEIN LYRIC PROTEIN; 1.
DR   PANTHER; PTHR23251:SF0; PROTEIN LYRIC; 1.
DR   Pfam; PF15686; LYRIC; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell junction; Cytoplasm;
KW   Endoplasmic reticulum; Membrane; Nucleus; Phosphoprotein;
KW   Reference proteome; Tight junction; Transmembrane; Transmembrane helix.
FT   CHAIN           1..581
FT                   /note="Protein LYRIC"
FT                   /id="PRO_0000084535"
FT   TOPO_DOM        1..49
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        50..70
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        71..581
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          1..71
FT                   /note="Activation of NF-kappa-B"
FT                   /evidence="ECO:0000250"
FT   REGION          72..168
FT                   /note="Interaction with BCCIP"
FT                   /evidence="ECO:0000250"
FT   REGION          77..221
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          100..204
FT                   /note="Interaction with RELA"
FT                   /evidence="ECO:0000250"
FT   REGION          280..581
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          380..442
FT                   /note="Lung-homing for mammary tumors"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        105..143
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        170..198
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        280..301
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        311..336
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        343..368
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        419..439
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        451..478
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        487..501
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        521..565
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         142
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86UE4"
FT   MOD_RES         179
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86UE4"
FT   MOD_RES         215
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86UE4"
FT   MOD_RES         250
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86UE4"
FT   MOD_RES         263
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80WJ7"
FT   MOD_RES         297
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         305
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86UE4"
FT   MOD_RES         310
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86UE4"
FT   MOD_RES         343
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86UE4"
FT   MOD_RES         368
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86UE4"
FT   MOD_RES         414
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86UE4"
FT   MOD_RES         425
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         456
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         477
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86UE4"
FT   MOD_RES         493
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86UE4"
FT   MOD_RES         495
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86UE4"
FT   MOD_RES         567
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         248..269
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_012227"
FT   VAR_SEQ         349..382
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_012228"
SQ   SEQUENCE   581 AA;  63969 MW;  9F86534238C3513C CRC64;
     MAARSWQDEL AQQAEEGSAR LRELLSVGLG FLRTELGLDL GLEPKRYPSW VILVGTGALG
     LLLLFLLGYG WAAACAGARK KRRSPPRKRE EVTPPTPAPE DPAQLKNLRS EEQKKKNRKK
     LPEKPKPNGR TVEIPEDEVV RTPRSITAKQ PPETDKKNEK SKKNKKKSKS DAKAVQNSSR
     HDGKEVDEGA WETKISHREK RQQRKRDKVL TDSGSLDSTI PGIENTITVT TEQLTTASFP
     VGSKKNKGDS HLNVQVSNFK SGKGDSTLQV SSGLNENITV NGGGWSEKSV KLSSQLSAGE
     EKWNSVPPAS AGKRKTEQSA WTQDPGDTNA NGKDWGRNWS DRSIFSGIGS TAEPVSQSTT
     SDYQWDGSRN QPHIDDEWSG LNGLSSADPS SDWNAPAEEW GNWVDEDRAS LLKSQEPISN
     DQKDSDDDKE KGEGALPTGK SKKKKKKKKK QGEDNSITQD TEDLEKDTRE ELPVNTSKAR
     PKQEKACSLK TMSTSDPVEV LIKNSQPIKT LPPAISAEPS VTLSKGDSDK SSSQVPPMLQ
     DTDKPKSNAK QNSVPPSQTK SETNWESPKQ IKKKKKARRE T
//
